Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Feb 18, 2026-- Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition,” “ACI,” or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating …